Peter M. Grob

4.0k citations

38 papers · 3.1k indexed · 2 hit papers · h-index 22

Impact in

Virology top 1%
- HIV Research and Treatment
Hepatology top 2%
- Hepatitis C virus research

Papers in ⓘ

Virology 13
- HIV Research and Treatment 13
Infectious Diseases 15
- HIV/AIDS drug development and treatment 15

Co-authors: Mark Bothwell (5 shared papers)Anne G. Graham (3 shared papers)Laurie Churchill (4 shared papers)Alonzo H. Ross (3 shared papers)Susan Pav (3 shared papers)Christopher Pargellis (2 shared papers)Thomas D. Gilmore (2 shared papers)Eugene R. Hickey (2 shared papers)
Journals: Journal of Medicinal Chemistry (5 papers)Vaccine (3 papers)Journal of Biological Chemistry (3 papers)Biochemistry (2 papers)Proceedings of the National Academy of Sciences (2 papers)
Partner nations: United States Switzerland Japan

In The Last Decade

Peter M. Grob

37 papers receiving 3.0k citations

Hit Papers

align trajectories log scale

Inhibition of p38 MAP kinase by utilizing a novel allosteric binding site 2002 · 669 citations

Peers

Countries citing papers authored by Peter M. Grob

Since Specialization

Citations

This map shows the geographic impact of Peter M. Grob's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Peter M. Grob with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Peter M. Grob more than expected).

Fields of papers citing papers by Peter M. Grob

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Peter M. Grob. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Peter M. Grob. The network helps show where Peter M. Grob may publish in the future.

Co-authors

The 25 scholars most cited alongside Peter M. Grob, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Peter M. Grob Line = papers co-authored together Peter M. Grob links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Showing the 20 most-cited of 38 papers — load more, or switch the sort, to bring in the rest.

#	Work
1	Clinical progression, survival, and immune recovery during antiretroviral therapy in patients with HIV-1 and hepatitis C virus coinfection: the Swiss HIV Cohort Study The Lancet ·Gilbert Greub, B Ledergerber, Manuel Battegay, Peter M. Grob, Lionel Perrin, Hansjakob Furrer, Philipp Bürgisser, P Erb, Katia Boggian, J-C Piffaretti, B Hirschel, P Janin, P Francioli, Markus Flepp, Amalio Telenti Hit paper breakdown →	2000	692
2	Inhibition of p38 MAP kinase by utilizing a novel allosteric binding site Nature Structural Biology ·Christopher Pargellis, Liang Tong, Laurie Churchill, Pier F. Cirillo, Thomas D. Gilmore, Anne G. Graham, Peter M. Grob, Eugene R. Hickey, Neil Moss, Susan Pav, John R. Regan Hit paper breakdown →	2002	669
3	Characterization of nerve growth factor receptor in neural crest tumors using monoclonal antibodies. Proceedings of the National Academy of Sciences ·Alonzo H. Ross, Peter M. Grob, Mark Bothwell, D Elder, Carolyn S. Ernst, Nadia Marano, B.F.D. Ghrist, C.C. Slemp, Meenhard Herlyn, Barbara Atkinson	1984	281
4	INTRATHECAL AND SERUM INTERLEUKIN-6 AND THE ACUTE-PHASE RESPONSE IN PATIENTS WITH SEVERE TRAUMATIC BRAIN INJURIES Shock ·Thomas Kossmann, Volkmar Hans, Hans-Georg Imhof, Reto Stocker, Peter M. Grob, O. Trentz, Maria Cristina Morganti-Kossmann	1995	229
5	A novel, dipyridodiazepinone inhibitor of HIV-1 reverse transcriptase acts through a nonsubstrate binding site Biochemistry ·Joseph C. Wu, Thomas C. Warren, Julian Adams, John Proudfoot, Jerry W. Skiles, Palayakotai R Raghavan, Caroline Perry, Ian Potocki, Peter R. Farina, Peter M. Grob	1991	158
6	Characterization of the human melanoma nerve growth factor receptor. Journal of Biological Chemistry ·Peter M. Grob, Alonzo H. Ross, Hilary Koprowski, Mark Bothwell	1985	131
7	Characterization of a receptor for human monocyte-derived neutrophil chemotactic factor/interleukin-8. Journal of Biological Chemistry ·Peter M. Grob, Eva David, Thomas C. Warren, R. DeLeon, Peter R. Farina, Carol Homon	1990	113
8	Affinity labeling and partial purification of nerve growth factor receptors from rat pheochromocytoma and human melanoma cells. Proceedings of the National Academy of Sciences ·Peter M. Grob, Catherine H. Berlot, Mark Bothwell	1983	85
9	Purification and Amino Terminal Sequencing of Human Melanoma Nerve Growth Factor Receptor Journal of Neurochemistry ·Nadia Marano, Bernhard Dietzschold, James J. Barley, Gina C. Schatteman, Susan Thompson, Peter M. Grob, Alonzo H. Ross, Mark Bothwell, Barbara Atkinson, Hilary Koprowski	1987	83
10	Effect of Structural Modification of Enol−Carboxamide-Type Nonsteroidal Antiinflammatory Drugs on COX-2/COX-1 Selectivity Journal of Medicinal Chemistry ·Edward S. Lazer, Clara K. Miao, Charles L. Cywin, Ronald Sorcek, Hin-Chor Wong, Zhaoxing Meng, Ian Potocki, MaryAnn Hoermann, Roger J. Snow, Matt A. Tschantz, Terence A. Kelly, Daniel W. McNeil, Simon J. Coutts, Laurie Churchill, Anne G. Graham, Eva David, Peter M. Grob, Wolfhard Engel, Hans Meier, G. Trummlitz	1997	74
11	Nonnucleoside Inhibitors of HIV-1 Reverse Transcriptase: Nevirapine as a Prototype Drug AIDS Research and Human Retroviruses ·Peter M. Grob, Joseph C. Wu, K.A. Cohen, Richard H. Ingraham, Cheng-Kon Shih, Karl D. Hargrave, TARI L. MCTAGUE, Vincent J. Merluzzi	1992	73
12	Selective inhibition of human cyclo-oxygenase-2 by meloxicam Inflammopharmacology ·Laurie Churchill, Anne G. Graham, C-K. Shih, Daniel Pauletti, Peter R. Farina, Peter M. Grob	1996	73
13	The influence of leukocyte filtration during cardiopulmonary bypass on postoperative lung function: A clinical study Journal of Thoracic and Cardiovascular Surgery ·Tomislav Meštrović, Martin Tönz, Ludwig K. von Segesser, Miralem Pašić, Peter M. Grob, Jörg Fehr, Burkhardt Seifert, M Turina	1995	70
14	Steady state kinetics and inhibition of HIV-1 reverse transcriptase by a non-nucleoside dipyridodiazepinone, BI-RG-587, using a heteropolymeric template Nucleic Acids Research ·Elizabeth B. Kopp, John Miglietta, Anthony Shrutkowski, Cheng-Kon Shih, Peter M. Grob, Mark T. Skoog	1991	47
15	Novel Non-Nucleoside Inhibitors of Human Immunodeficiency Virus Type 1 Reverse Transcriptase. 6. 2-Indol-3-yl- and 2-Azaindol-3-yl- dipyridodiazepinones Journal of Medicinal Chemistry ·Terence A. Kelly, Daniel W. McNeil, Janice Rose, Eva David, Cheng-Kon Shih, Peter M. Grob	1997	43
16	Modification of nerve growth factor receptor properties by wheat germ agglutinin. Journal of Biological Chemistry ·Peter M. Grob, Mark Bothwell	1983	37
17	Novel Non-nucleoside Inhibitors of Human Immunodeficiency Virus Type 1 Reverse Transcriptase. 5. 4-Substituted and 2,4-Disubstituted Analogs of Nevirapine Journal of Medicinal Chemistry ·Tracy Kelly, John Proudfoot, Daniel W. McNeil, U R Patel, Eva David, Karl D. Hargrave, Peter M. Grob, Mario Cardozo, Atul Agarwal, Julian Adams	1995	32
18	Prophylaxis against HIV-1 infection in chimpanzees by nevirapine, a nonnucleoside inhibitor of reverse transcriptase Nature Medicine ·Peter M. Grob, Yunzhen Cao, Elizabeth Muchmore, David D. Ho, Steve Norris, Joseph Pav, Cheng-Kon Shih, Julian Adams	1997	28
19	Novel Nonnucleoside Inhibitors of HIV-1 Reverse Transcriptase. 7. 8-Arylethyldipyridodiazepinones as Potent Broad-Spectrum Inhibitors of Wild-Type and Mutant Enzymes Journal of Medicinal Chemistry ·Janice M. Klunder, MaryAnn Hoermann, Charles L. Cywin, Eva David, Janice R. Brickwood, Racheline Schwartz, Kevin Barringer, Daniel Pauletti, Cheng-Kon Shih, David A. Erickson, Christopher L. Sorge, David Joseph, Susan E. Hattox, Julian Adams, Peter M. Grob	1998	27
20	INACTIVATION OF CELL SURFACE RECEPTORS BY PHEOPHORBIDE a, A GREEN PIGMENT ISOLATED FROM Psychotria acuminata Photochemistry and Photobiology ·Jan A. Gliński, Eva David, Thomas C. Warren, G.E. Hansen, Scott F. Leonard, Phillip Pitner, Susan Pav, Rosita Arvigo, Michael J. Balick, Eligio Panti, Peter M. Grob	1995	26

About Peter M. Grob

Peter M. Grob is a scholar working on Virology, Infectious Diseases, Hepatology, Immunology and Allergy and Immunology, having authored 38 papers that have together received 3.1k indexed citations. Recurring topics across this work include HIV/AIDS drug development and treatment (15 papers), HIV Research and Treatment (13 papers), Pneumocystis jirovecii pneumonia detection and treatment (4 papers), Hepatitis C virus research (4 papers), Glycosylation and Glycoproteins Research (4 papers), Monoclonal and Polyclonal Antibodies Research (4 papers), Hepatitis B Virus Studies (3 papers) and Inflammatory mediators and NSAID effects (3 papers). The work is most often cited by research in Virology (542 citations), Hepatology (517 citations), Infectious Diseases (776 citations), Developmental Neuroscience (112 citations) and Cellular and Molecular Neuroscience (485 citations). Peter M. Grob has collaborated with scholars based in United States, Switzerland and Japan. Frequent co-authors include Mark Bothwell, Anne G. Graham, Laurie Churchill, Alonzo H. Ross, Susan Pav, Christopher Pargellis, Thomas D. Gilmore, Eugene R. Hickey, Liang Tong and Neil Moss. Their work appears in journals such as Journal of Medicinal Chemistry, Vaccine, Journal of Biological Chemistry, Biochemistry and Proceedings of the National Academy of Sciences.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact